Dr. Daniels Discusses Treatment Options in Thyroid Cancer | OncLive

Dr. Daniels Discusses Treatment Options in Thyroid Cancer

October 27, 2017

Gregory A. Daniels, MD, PhD, medical oncologist, associate professor of medicine, UC San Diego Health, discusses treatment options for patients with thyroid cancer.

Gregory A. Daniels, MD, PhD, medical oncologist, associate professor of medicine, UC San Diego Health, discusses treatment options for patients with thyroid cancer.

The 2 FDA-approved agents for the treatment of patients with thyroid cancer are sorafenib (Nexavar) and lenvatinib (Lenvima). These are tyrosine kinase inhibitors that target VEGF1, VEGF2, and VEGF3, but these are not necessarily the driver mutations, says Daniels.

The hype of personalized medicine now is making its way into thyroid cancer, says Daniels, and a genetic-based approach to treatment may be in the future for this disease.


x